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ABSTRACT 
Aim: To develop a new Brief Scale of Self-Rated Health Condition with Acute 
Schizophrenia (BsHAS) and to examine its reliability, validity and relationship to psychiatric 
symptoms. 
Methods: We examined the reliability and validity of the BsHAS consisting of four 
items (physical health condition, mood, interpersonal fatigue and interest) for 199 inpatients 
with acute schizophrenia and compared the patients' subjective health conditions as assessed 
by the BsHAS with their objective psychiatric symptoms. 
Results and Discussion: Cronbach’s α coefficient was 0.79, indicating that the 
reliability of the scale was sufficient. These four items chosen from the previous studies were 
approved by an expert panel, which suggested that the scale has content validity. The BsHAS 
total score was significantly improved at discharge. However, the effect size was only -0.24. 
Especially, improvement was not recognized in the interpersonal fatigue item. These 
findings suggest that some patients were discharged without realizing the 
improvement of their health condition. The patients  answered all questions without 
subsequently showing deteriorating symptoms, suggesting that the scale can be 
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applied to acute-phase patients with schizophrenia. No obvious relation was 
recognized between the patients' subjective health condition as assessed by the 
BsHAS and their objective psychiatric symptoms. This result suggests that the 
BsHAS can provide additional information to the objective assessment of psychiatric 
symptoms. 
Conclusion: These results show that the BsHAS can help psychiatric 
professionals to know patients' subjective health conditions , and that the longitudinal 
use of this scale may be useful for evaluating the degree of recovery from 
schizophrenia. 
 
Key words: 
health, reliability, validity, self-rating scale, schizophrenia 
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INTRODUCTION 
Recently, in a policy shift from institutional to community care in Japan, Japanese 
psychiatric professionals have tried to improve the quality of care in acute psychiatric 
inpatient care units and introduce rehabilitation programs at an earlier phase of treatment to 
decrease hospital long-stays and readmission.
1, 2
 Accordingly, psychiatric professionals need 
to more closely monitor the recovery of schizophrenia patients. In our acute psychiatric 
inpatient care unit, we have introduced rehabilitation programs and monitor the patients’ 
symptoms by using objective scales to decrease hospital long-stays and readmission. But 
readmission due to treatment discontinuation is not uncommon in our involuntarily admitted 
patients with acute schizophrenia. 
In addition to objective evaluation by psychiatric professionals, subjective 
evaluation by patients is also important.
3-7
 Fleischhacker WW et al. reported that 
schizophrenia patients’ subjective evaluation in functioning and well-being is a different 
outcome dimension from objective evaluation of psychopathology.
8
 Thus, we hypothesized 
that knowing a patient's subjective health condition, i.e., evaluating the effect of treatment 
from the patient’s point of view, would contribute to the recovery process from acute 
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psychosis. We also believed that focusing on the patient’s subjective health condition would 
lead to the patient’s positive participation in the treatment. The psychiatric professionals can 
know how patients with schizophrenia grasp their own health condition
 
by subjective 
evaluation scales.
9-11
 To assess the health of sub-acute phase psychiatric patients, a 13-item 
self-administered scale was made in Japan.
12
 When the authors applied these subjective 
evaluation scales to involuntarily admitted patients with acute schizophrenia in our acute 
psychiatric inpatient care unit, many patients did not complete these scales because they were 
too long and complicated. We thought that an executable scale was more than necessary for 
involuntarily admitted patients with acute schizophrenia, and that a briefer and simpler scale 
was needed. 
Therefore, we developed the Brief Scale of Self-Rated Health Condition with Acute 
Schizophrenia (BsHAS) that even involuntarily admitted patients could complete. We also 
examined its reliability and validity and its relationship to objective psychiatric symptoms. 
 
METHODS 
Development of the BsHAS 
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The authors (OH, YK, TM and HT), two psychiatrists and two occupational 
therapists with more than ten years of experience in psychiatry selected four items for the 
BsHAS from previous studies
9-12
 with which involuntarily admitted patients with acute 
schizophrenia can assess their health condition. Health condition has physical, psychological 
and social dimensions.
13
 We selected a physical health item to assess the physical dimension, 
a mood item to assess the psychological dimension, and an interpersonal fatigue item and an 
interest item to assess the social dimension. We used simple questions for each item, such as 
"How would you describe your physical health?" for the physical health condition item, "How 
are you feeling?" for the mood item, "Do you feel exhausted when other people are present?" 
for the interpersonal fatigue item and "Have you enjoyed something, recently?" for the 
interest item. The responses were graded with a five-point Likert scale. The questions and 
answers of the BsHAS were shown in the Appendix. The answer for each item was scored 0 
to 4 (with higher scores indicating better health condition), and the sum of all scores was the 
BsHAS total score. 
A psychiatric professional handed the scale and a pencil to the patient and asked 
them to respond to the questions on the scale based on their experiences in the last few days.  
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Test-retest reliability of the BsHAS 
We examined the test-retest reliability of the BsHAS in a preliminary study. The 
test–retest reliability of the scale was assessed by repeated administration of the scale to 64 
stable schizophrenia inpatients with a 1-month interval between assessments (April 2008 to 
May 2008). The subjects consisted of 46 males and 18 females. The median (inter-quartile 
range) age of the patients was 51.5 (22) years, the median number of hospitalizations was 5 
(6) times, the median duration of illness was 27 (23.8) years and the median antipsychotics 
dose (equivalent to chlorpromazine) was 801.5 (880) mg/day. The intraclass correlation 
coefficients via one-way analysis of variance
 14
 were calculated from the BsHAS score of test 
and retest. 
Subjects 
This survey was conducted from April 2008 to March 2011. Inclusion criteria were: 
(i) diagnosis of schizophrenia with the ICD-10;
15
 (ii) involuntary hospitalization; (iii) 
participation in rehabilitation programs in the acute psychiatric inpatients care unit. The 
patients in this study were involuntarily admitted to our hospital with the informed consent of 
their guardians/family members. These patients were not competent to consent for their 
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admission because of their severe psychiatric symptoms. When the attending doctor judged 
that the patient was competent to join the rehabilitation programs and this study, the doctor 
obtained oral informed consent to participate in the programs and the first author obtained 
written, informed consent to participate in this study from the patient. We thought that the risk 
of this study to the patients was negligible and thus did not ask guardians/family members for 
consent for the patients to participate in the study. Patients received all the services as usual 
whether they chose to participate or not. The study was performed in accordance with the 
Helsinki Declaration. The present study was approved by the Medical Research Ethics 
Committee of Kofu Hospital of Hyogo Prefecture (Rd No. 20084). 
Of a total of 713 admitted patients, 333 met the inclusion criteria (i) and (ii) (Figure 
1). All were inpatients. Of these patients, 225 patients were invited to participate in the 
rehabilitation programs, while the remaining 108 patients were not because of discharge 
before program participation (96 patients) or high risk of harming others (12 patients). Of the 
225 patients, 26 patients refused to participate in the study, leaving 199 consenting patients in 
the study. None of the 199 patients dropped out of the study. 
The subjects consisted of 81 males and 118 females (Table 1). The median 
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(inter-quartile range) age was 40 (21) years, the median number of hospitalizations was 2 (3) 
times and the median duration of illness was 10 (19) years. All subjects were taking 
antipsychotics with a median chlorpromazine equivalent dose of 800 (675) mg/day. The 
median duration from admission to inclusion in this study was 27 (25) days and the median 
length of hospitalization was 88 (42) days. 
Study design and statistical analysis 
We examined the reliability and validity of the BsHAS and then compared the 
patients’ subjective health condition as assessed by the BsHAS and their objective psychiatric 
symptoms. 
After examining the test-retest reliability of the BsHAS in preliminary studies, we 
examined its internal reliability. The Cronbach’s α coefficients16 were calculated from the 
BsHAS item score at the baseline. 
The content validity of the BsHAS was examined by an expert panel (five 
psychiatrists and one psychiatric nurse) with more than ten years of clinical experience and 
who was unfamiliar with the development process of the BsHAS. Responsiveness of the 
BsHAS was assessed with the Wilcoxon signed rank test and Cohen's d.
17
 Cohen's d is a 
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standardized measure of effect size and provides information on the amount of change in the 
measure relative to the variation within the measure. Cohen's d is computed as the difference 
between the baseline and discharge scores divided by the standard deviation of baseline 
scores. Usability was expressed as the number of missing data and the number of subjects 
with deteriorated psychiatric symptoms after administration of the scale. 
The subjects’ objective psychiatric symptoms were evaluated with the Brief 
Psychiatric Rating Scale (BPRS),
18, 19
 which was rated by attending psychiatrists who were 
not involved in this study. The correlation between the BsHAS and BPRS scores was tested 
with Spearman’s rank correlation coefficients. As a guideline, correlation coefficients from ± 
0.00 to ± 0.20 indicate no relationship; from ± 0.20 to ± 0.40, a fair degree of relationship; 
from ± 0.40 to ± 0.70, a moderate relationship; and above 0.70, an excellent relationship.
16
  
All statistical tests were two-tailed, and the significance level was set at p<0.05. 
Statistics were analyzed with PASW Statistics 18 (SPSS). 
 
RESULTS 
Reliability 
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In a preliminary study, the test–retest reliability of the scale was assessed. The 
intraclass correlation coefficients between the score of test-retest of the BsHAS physical 
health condition item score was 0.61 (p<0.001), mood item score was 0.47 (p<0.001), 
interpersonal fatigue item score was 0.45 (p=0.001) and interest item score was 0.61 
(p<0.001). Therefore, the test-retest reliability of the BsHAS was moderate. 
The Cronbach’s α coefficient calculated by the BsHAS item score at baseline was 
0.79. A Cronbach’s α coefficient greater than 0.7 indicates sufficient reliability.16 Therefore 
the internal reliability of the BsHAS was assumed to be sufficient. 
Validity 
The expert panel's opinion was that the BsHAS had good content validity for acute 
schizophrenia patients’ subjective health condition. 
The distribution of the BsHAS scores in this study is shown in Figure 2. The 
BsHAS total score was significantly improved at discharge (Table 2). In the items, the 
physical health condition, mood and interest items were also significantly improved at 
discharge, but the interpersonal fatigue item was not significantly improved (Table 2). The 
effect sizes in terms of changes in the BsHAS are shown in Table 2. Cohen defined the effect 
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size of ± 0.20 as small, ± 0.50 as moderate and ± 0.80 as large.
20
 According to Samsa et al., an 
effect size of at least ± 0.20 is recommended as the standard for supporting sensitivity to 
change.
20
 The effect sizes in the total BsHAS and the physical health condition and interest 
items were small, and the effect sizes in the mood and interpersonal fatigue were less than the 
sensitivity standard.  
All subjects answered the BsHAS within 3 minutes without any difficulty, and no 
missing data was observed. None of the subjects showed deteriorated psychiatric symptoms 
after administration of the BsHAS. 
Relationship between subjective health condition and psychiatric symptoms 
Changes in the BPRS scores are shown in Table 2. The psychiatric symptoms 
assessed with the BPRS were significantly improved at discharge. The correlations 
(Spearman's rank correlation coefficient) between the BsHAS and the BPRS are shown in 
Table 3. No clear relationship was found between the BsHAS and the BPRS at baseline, 
discharge and change from baseline. 
 
DISCUSSION 
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All questions were answered by all subjects so there were no missing data. There 
were no subjects whose symptoms deteriorated after administration of the scale. These 
findings suggested that the BsHAS did not impose a load on patients with acute schizophrenia 
and therefore it can be used safely in clinical practice. 
The BsHAS total score was significantly improved at discharge. However, the 
effect size showed a response of -0.24, indicating that the responsiveness of the scale was 
small. Slight improvements were observed in the physical health condition, mood and interest 
items, but no improvement was observed in the interpersonal fatigue item. This is consistent 
with a previous report, which found that interpersonal fatigue of schizophrenia showed the 
slowest improvement.
21
 Most patients might not recover from their own interpersonal fatigue 
at discharge.  
No clear relationship was observed between the subjective health condition 
assessed with the BsHAS and the psychiatric symptoms assessed with the BPRS. Our results 
resemble those of previous studies
8, 22 
in which there was only a weak relationship between 
the subjective health condition and the objective psychiatric symptoms evaluated by the raters 
for patients with chronic schizophrenia. Patient-reported improvement in functioning and 
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well-being was reported to be different from investigator-rated improvement of 
psychopathology,
8
 which suggests the necessity of subjective assessment as an evaluation 
method for outcomes. The results of the study suggest that psychiatric inpatient care should 
target these subjective health conditions as well as objective psychiatric symptoms. 
This study has three main limitations. First, the examination based on the data of 
stable inpatients does not fully prove the test-retest reliability of the BsHAS. Second, the 
subjects were involuntarily hospitalized, and were invited to participate in rehabilitation 
programs by the attending doctor. The representativeness of the subjects in this study might 
restrict the possibility of generalization of the findings. Third, there is no absolute scale for 
subjective health condition evaluation for patients with acute schizophrenia, so the concurrent 
validity of the scale cannot be determined absolutely. To clarify the clinical significance of the 
BsHAS, we are planning a follow-up study at multiple medical facilities to examine the 
relationship between the patients’ subjective health condition and their positive participation 
in the treatment. 
 
CONCLUSIONS 
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Our results show that the BsHAS can be used even for involuntarily admitted 
patients with acute schizophrenia. 
In the treatment of patients with acute schizophrenia, improvement of the health 
condition assessed by the BsHAS was small and no improvement was observed in the 
interpersonal fatigue item. Most patients might not recover from their own interpersonal 
fatigue at discharge. The results of the study suggest that psychiatric inpatient care should 
target these subjective health conditions as well as objective psychiatric symptoms. 
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APPENDIX 
Items and grades of rating in the Brief Self-Rated Scale of Health Condition with Acute 
Schizophrenia (BsHAS) 
1. "How would you describe your physical health?" 
0 Poor, 1 Fair, 2 Neither poor nor good, 3 Good, 4 Very good 
2. "How are you feeling?" 
0 Poor, 1 Fair, 2 Neither poor nor good, 3 Good, 4 Very good 
3. "Do you feel exhausted when other people are present?" 
0 Extremely, 1 Quite a bit, 2 Moderately, 3 Slightly, 4 Not at all 
4. "Hove you enjoyed something, recently?" 
0 Not at all, 1 A few times, 2 Fairly often, 3 Usually, 4 Always 
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Table 1. Baseline Characteristics of patients 
 
  
N
Median
(Inter-quartile range)
Male 81
Female 118
Schizophrenia 148
Persistent delusional disorders 3
Acute and transient psychotic disorders 21
Schizoaffective 25
Unspecified nonorganic psychosis 2
　40 (21)
　2 (3)
　10 (19)
Yes 148
No 49
No certificate 2
Graduated junior high school 41
Graduated high school 92
Graduated junior college 22
Graduated college 42
No certificate 2
Alone 34
With someone 165
Only atypical antipsychotics 135
Atypical+Typical 59
Only typical antipsychotics 4
No 1
800 (675)
Job experience 
Education
Living situation on admission
Medication
Dose antipsychotics
chlorpromazine equivalent (mg/day)
Duration of illness (Years)
Characteristic
Gender 
Diagnosis 
Age (Years)
Number of hospitalizations (Times)
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Table 2. Changes in the BsHAS and the BPRS scores 
 
 
  
Mean SD Mean SD
9.27 3.88 10.16 3.54 ＜0.001 -0.24 **
Physical health condition (0~4) 2.41 1.18 2.64 1.04 0.012 -0.21 *
Mood (0~4) 2.55 1.15 2.75 1.05 0.027 -0.18 *
Interpersonal fatigue (0~4) 2.05 1.28 2.15 1.18 0.225 -0.08
Interest (0~4) 2.27 1.32 2.61 1.18 ＜0.001 -0.27 **
40.62 12.48 32.84 9.76 ＜0.001 0.70 **
Effect Size
d
BPRS; Brief Psychiatric Rating Scale
*p  ＜0.05, **p  ＜0.01.
Total (0~16)
BPRS (N=199)
Total (18~126)
p value; Wilcoxon signed rank test
d ; Cohen's effect size
BsHAS; Brief Scale of Self-Rated Health Condition with Acute Schizophrenia
BsHAS (N=199)
Variables
Baseline Discharge
p value
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Table 3. Correlations (Spearman's rank correlation coefficient) between the BsHAS and 
the BPRS at baseline, discharge and change from baseline (N=199) 
 
  
-0.22 **
Physical health condition -0.23 **
Mood -0.19 **
Interpersonal fatigue -0.23 **
Interest -0.05
-0.29 ***
Physical health condition -0.21 **
Mood -0.28 ***
Interpersonal fatigue -0.28 ***
Interest -0.11
-0.18 *
Physical health condition -0.15 *
Mood -0.18 *
Interpersonal fatigue -0.08
Interest -0.07
Baseline Discharge
Change from
baseline
BsHAS; Brief Scale of Self-Rated Health Condition with Acute Schizophrenia
BPRS; Brief Psychiatric Rating Scale
*p  ＜0.05, **p ＜0.01, ***p ＜0.001.
Total
 BPRS (N=199)
Total
Baseline
Change from baseline
Discharge
Total
BsHAS (N=199)
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Figure 1. Study flowchart 
  
Admitted from April 2008 to March 2011
(N=713)
Met the inclusion criteria, (i) diagnosis of
schizophrenia and (ii) involuntary hospitalization
(N=333)
Analyzed
(N=199)
 Not invited to participate in rehabilitation programs
by the attending doctor
(N=108)
Discharged before program participation 96
 High risk of harm to others 12
Met the inclusion criterion, (iii) participation in
rehabilitation programs in the acute psychiatric
inpatients care unit
(N=225)
Refused consent
(N=26)
Consented
(N=199)
Dropped out
(N=0)
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Figure 2. Distributions of Scores of the BsHAS items in individuals with acute symptoms 
of schizophrenia at baseline and discharge 
1 3 4
Rating categories
Physical health condition and Mood; (0)Poor, (1)Fair, (2)Neither poor nor good, (3)Good, (4)Very good
Intpersonal fatigue; (0)Extremely, (1)Quite a bit, (2)Moderately, (3)Slightly, (4)Not at all
Interest; (0)Not at all, (1)A few times, (2)Fairly often, (3)Usually, (4)Always
baselinedischarge
200
150
100
50
0 2
baseline dischargebaseline discharge baseline discharge
0
Physical health
condition
Interest
N    (N=199)
Mood
Interpersonal
 fatigue
7 6
21 28
37
80
20
55
30
71
35
57
59
47
37
35
33
36
65
37
4
18
78
44
55
5
18
57
61
58
16
47
58
47
31
13
23
45
65
53
